Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

7.44
+0.11001.50%
Post-market: 7.40-0.0400-0.54%18:12 EDT
Volume:897.33K
Turnover:6.75M
Market Cap:754.08M
PE:-7.26
High:7.74
Open:7.51
Low:7.39
Close:7.33
Loading ...
Feb 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 17, 2024

Major Issues Report

Form 8-K - Current report
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 17, 2023

Major Issues Report

Form 8-K - Current report
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 16, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2023

Major Issues Report

Form 8-K - Current report
Oct 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 11, 2023

Major Issues Report

Form 8-K - Current report